Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Ruxolitinib

EBV viraemia, EBV gastritis and EBV positve diffuse large B cell lymphoma

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Puello Yocum B, et al. EBV-Gastritis Preceded the Development of Nasopharyngeal EBV (+) Diffuse Large B Cell Lymphoma in a Patient With Ruxolitinib-Induced Immunosuppression. International Journal of Surgical Pathology 31: 1340-1346, No. 7, Jan 2023. Available from: URL: https://dx.doi.org/10.1177/10668969221137525 [Summarised from an abstract] Puello Yocum B, et al. EBV-Gastritis Preceded the Development of Nasopharyngeal EBV (+) Diffuse Large B Cell Lymphoma in a Patient With Ruxolitinib-Induced Immunosuppression. International Journal of Surgical Pathology 31: 1340-1346, No. 7, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1177/​1066896922113752​5 [Summarised from an abstract]
Metadaten
Titel
Ruxolitinib
EBV viraemia, EBV gastritis and EBV positve diffuse large B cell lymphoma
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49753-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pembrolizumab

Case report

Multiple drugs